Global Anthrax Vaccine Market: By Type (Cell free PA Vaccines and Live Vaccines); Application (Animal and Human); End Users (Hospitals and Clinics, Veterinary Centers and Others), and Region— Market Forecast and Analysis for 2023–2031
The global anthrax vaccine market is expected to grow at a steady CAGR of 6.7%, fueled by increasing bioterrorism threats and growing awareness about the disease. As of 2022, the market was valued at US$ 599 million and is expected to surpass valuation of US$ 1,006.33 million by 2031. Read More
- Published On: 16-Jun-2023 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA0623468
| Report ID: AA0623468Request Sample
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
